Skip to content

BIORESTORATIVE THERAPIES, INC.: 10-K filed 2013-04-02

What BIORESTORATIVE THERAPIES, INC. reported in its annual report filed 2013-04-02 (fiscal FY 2012): 38 published measures, 101 facts as tagged in accession 0001144204-13-019421.

This filing

Form
10-K (annual report)
Filed
2013-04-02
Fiscal period
fiscal FY 2012
Accession
0001144204-13-019421 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-311,268,044USD
At 2011-12-31220,973USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-316,409,737USD
At 2011-12-313,907,370USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31-5,141,693USD
At 2011-12-31-3,686,397USD
At 2010-12-31-744,222USD
At 2009-12-31-51,087USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-6,536,722USD366
2008-12-30 to 2012-12-31-14,071,584USD1463
2011-01-01 to 2011-12-31-4,073,937USD365
2008-12-30 to 2011-12-31-7,534,862USD1097
2010-01-01 to 2010-12-31-2,263,799USD365
2009-01-01 to 2009-12-31-1,197,126USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-3,184,112USD366
2008-12-30 to 2012-12-31-6,927,277USD1463
2011-01-01 to 2011-12-31-2,810,867USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,533USD366
2008-12-30 to 2012-12-31165,776USD1463
2011-01-01 to 2011-12-3117,772USD365
2010-09-01 to 2010-09-3065,000USD30

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-01-01 to 2012-12-3115,589USD366
2008-12-30 to 2012-12-3115,589USD1463
2011-01-01 to 2011-12-310USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,115,500USD366
2008-12-30 to 2012-12-318,065,092USD1463
2011-01-01 to 2011-12-312,850,073USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,002,533USD366
2008-12-30 to 2012-12-31-1,137,452USD1463
2011-01-01 to 2011-12-3114,228USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-3159,407USD
At 2011-12-3194,827USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,848,246USD366
2008-12-30 to 2012-12-314,130,397USD1463
2011-01-01 to 2011-12-31456,826USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-5,572,452USD366
2008-12-30 to 2012-12-31-12,357,625USD1463
2011-01-01 to 2011-12-31-3,552,005USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3131,280USD
At 2011-12-31118,423USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-31591,813USD366
2008-12-30 to 2012-12-31880,311USD1463
2011-01-01 to 2011-12-31260,011USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-312,815,956USD
At 2011-12-313,907,370USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31771,429USD
At 2011-12-31426,184USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-04-061,000,000USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2008-12-30 to 2012-12-3132,000USD1463
2011-01-01 to 2011-12-314,000USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,586,734USD366
2008-12-30 to 2012-12-3112,371,907USD1463
2011-01-01 to 2011-12-313,552,005USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-12-3112,484USD
At 2011-12-310USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-3114,282USD366
2008-12-30 to 2012-12-3114,282USD1463
2011-01-01 to 2011-12-310USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-31416,180USD366
2008-12-30 to 2012-12-31439,800USD1463
2011-01-01 to 2011-12-3112,000USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-31744,241,911shares
At 2011-12-31607,683,811shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-318,179,354USD
At 2011-12-313,234,486USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-31165,462USD
At 2011-12-31162,929USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31106,055USD
At 2011-12-3168,102USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-12-311,177,357USD
At 2011-12-313,308USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-311,082,842USD
At 2011-12-31440,229USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-3118,433USD
At 2011-12-3146,915USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,224,721USD366
2008-12-30 to 2012-12-313,316,810USD1463
2011-01-01 to 2011-12-311,373,271USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-3137,953USD366
2008-12-30 to 2012-12-31182,767USD1463
2011-01-01 to 2011-12-3190,044USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-3190,404USD366
2008-12-30 to 2012-12-31235,586USD1463
2011-01-01 to 2011-12-3190,412USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-12-3152,451USD366
2008-12-30 to 2012-12-3152,819USD1463
2011-01-01 to 2011-12-31368USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-964,270USD366
2008-12-30 to 2012-12-31-1,713,959USD1463
2011-01-01 to 2011-12-31-521,932USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,925,000USD366
2011-01-01 to 2011-12-31200,000USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-3112,484USD366
2008-12-30 to 2012-12-3112,484USD1463
2011-01-01 to 2011-12-310USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31349,215USD366
2008-12-30 to 2012-12-31717,918USD1463
2011-01-01 to 2011-12-31268,516USD365

Inspect the source

Entity
BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
Captured
2026-09-19T11:18:28.483Z
SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))